Trials / Completed
CompletedNCT03179202
Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS)
A Post-Market Study of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Back Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 166 (actual)
- Sponsor
- SPR Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of electrical stimulation (low levels of electricity) on low back pain. This study involves the SPRINT Peripheral Nerve Stimulation (PNS) system. The System delivers mild electrical stimulation to the nerves in the low back. The System includes up to four small wires (called "Leads") that are placed through the skin into the muscles in the low back. The wires attach to device(s) worn on the body that deliver stimulation (called Stimulators).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SPRINT Peripheral Nerve Stimulation (PNS) System | The SPRINT PNS System is a device which delivers mild electrical stimulation to the muscles in the low back. The System includes up to four small wires (called "Leads") that are placed through the skin into the muscles in the low back. The wires attach to device(s) worn on the body that deliver stimulation (called Stimulators). The PNS System was approved by the FDA for up to 60 days of use for the management of acute and chronic pain, including back pain. |
Timeline
- Start date
- 2017-06-23
- Primary completion
- 2021-05-11
- Completion
- 2021-05-11
- First posted
- 2017-06-07
- Last updated
- 2022-08-05
- Results posted
- 2022-08-05
Locations
8 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03179202. Inclusion in this directory is not an endorsement.